Latest Insider Transactions at Mednax, Inc. (MD)
This section provides a real-time view of insider transactions for Mednax, Inc. (MD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MEDNAX, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MEDNAX, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
Curtis Pickert EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,664
+39.6%
|
-
|
|
Mar 01
2023
|
Lee Wood EVP, Natl & Market Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,044
-2.75%
|
$30,660
$15.74 P/Share
|
|
Mar 01
2023
|
Lee Wood EVP, Natl & Market Operations |
BUY
Grant, award, or other acquisition
|
Direct |
39,806
+34.91%
|
-
|
|
Mar 01
2023
|
James D Swift Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,909
-8.28%
|
$148,635
$15.74 P/Share
|
|
Mar 01
2023
|
James D Swift Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,758
+29.36%
|
-
|
|
Dec 31
2022
|
Mark S Ordan |
SELL
Payment of exercise price or tax liability
|
Direct |
98,932
-28.54%
|
$1,385,048
$14.86 P/Share
|
|
Nov 21
2022
|
Mark S Ordan |
SELL
Open market or private sale
|
Direct |
22,166
-6.01%
|
$332,490
$15.45 P/Share
|
|
Nov 07
2022
|
James D Swift Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
24,000
-21.44%
|
$360,000
$15.31 P/Share
|
|
Sep 26
2022
|
Dominic J Andreano EVP, General Counsel and Secy |
SELL
Payment of exercise price or tax liability
|
Direct |
4,267
-2.2%
|
$68,272
$16.81 P/Share
|
|
May 12
2022
|
Shirley A Weis |
BUY
Grant, award, or other acquisition
|
Direct |
8,480
+24.81%
|
-
|
|
May 12
2022
|
Guy P Sansone |
BUY
Grant, award, or other acquisition
|
Direct |
8,480
+17.86%
|
-
|
|
May 12
2022
|
John M. Starcher Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
8,480
+25.09%
|
-
|
|
May 12
2022
|
Roger Md Medel Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,480
+1.12%
|
-
|
|
May 12
2022
|
Laura A Linynsky |
SELL
Grant, award, or other acquisition
|
Direct |
8,480
-50.0%
|
-
|
|
May 12
2022
|
Michael A. Rucker |
BUY
Grant, award, or other acquisition
|
Direct |
8,480
+22.73%
|
-
|
|
May 12
2022
|
Thomas Mc Eachin |
BUY
Grant, award, or other acquisition
|
Direct |
8,480
+25.09%
|
-
|
|
Mar 01
2022
|
Mark S Ordan |
SELL
Payment of exercise price or tax liability
|
Direct |
20,691
-5.31%
|
$475,893
$23.47 P/Share
|
|
Mar 01
2022
|
Mark S Ordan |
BUY
Grant, award, or other acquisition
|
Direct |
152,506
+17.97%
|
-
|
|
Mar 01
2022
|
Dominic J Andreano EVP, General Counsel and Secy |
SELL
Payment of exercise price or tax liability
|
Direct |
6,635
-3.31%
|
$152,605
$23.47 P/Share
|
|
Mar 01
2022
|
Dominic J Andreano EVP, General Counsel and Secy |
BUY
Grant, award, or other acquisition
|
Direct |
58,824
+13.74%
|
-
|
|
Mar 01
2022
|
Mary Ann E Moore EVP, General Counsel & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,525
-3.25%
|
$35,075
$23.47 P/Share
|
|
Mar 01
2022
|
Mary Ann E Moore EVP, General Counsel & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
32,680
+30.34%
|
-
|
|
Mar 01
2022
|
C Marc Richards EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,874
-4.49%
|
$158,102
$23.47 P/Share
|
|
Mar 01
2022
|
C Marc Richards EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
61,003
+18.27%
|
-
|
|
Mar 01
2022
|
Roger Mack Hinson Pres., PDX & OBX Medical Group |
SELL
Payment of exercise price or tax liability
|
Direct |
10,244
-8.56%
|
$235,612
$23.47 P/Share
|
|
Jan 11
2022
|
Roger Md Medel Director |
SELL
Open market or private sale
|
Direct |
40,107
-5.14%
|
$1,042,782
$26.58 P/Share
|
|
Jan 10
2022
|
Roger Md Medel Director |
SELL
Open market or private sale
|
Direct |
59,893
-7.13%
|
$1,557,218
$26.44 P/Share
|
|
Jan 05
2022
|
Roger Md Medel Director |
SELL
Open market or private sale
|
Direct |
12,639
-1.48%
|
$341,253
$27.42 P/Share
|
|
Jan 04
2022
|
Roger Md Medel Director |
SELL
Open market or private sale
|
Direct |
87,361
-9.3%
|
$2,358,747
$27.43 P/Share
|
|
Dec 31
2021
|
Roger Md Medel Director |
SELL
Open market or private sale
|
Direct |
6,564
-0.69%
|
$177,228
$27.16 P/Share
|
|
Dec 30
2021
|
Roger Md Medel Director |
SELL
Open market or private sale
|
Direct |
45,397
-4.58%
|
$1,225,719
$27.19 P/Share
|
|
Dec 29
2021
|
Roger Md Medel Director |
SELL
Open market or private sale
|
Direct |
25,000
-2.46%
|
$675,000
$27.28 P/Share
|
|
Dec 28
2021
|
Roger Md Medel Director |
SELL
Open market or private sale
|
Direct |
44,514
-4.2%
|
$1,201,878
$27.28 P/Share
|
|
Dec 27
2021
|
Roger Md Medel Director |
SELL
Open market or private sale
|
Direct |
66,868
-5.93%
|
$1,805,436
$27.17 P/Share
|
|
Nov 10
2021
|
John C Pepia Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.92%
|
$140,000
$28.45 P/Share
|
|
Nov 10
2021
|
Roger Mack Hinson Pres., PDX & OBX Medical Group |
SELL
Open market or private sale
|
Direct |
8,800
-7.57%
|
$246,400
$28.38 P/Share
|
|
Oct 29
2021
|
John C Pepia Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
9,238
-8.33%
|
$240,188
$26.87 P/Share
|
|
Oct 28
2021
|
Roger Md Medel Director |
SELL
Open market or private sale
|
Direct |
10,387
-0.91%
|
$301,223
$29.0 P/Share
|
|
Oct 04
2021
|
Roger Md Medel Director |
SELL
Open market or private sale
|
Direct |
1,270
-0.11%
|
$36,830
$29.0 P/Share
|
|
Sep 02
2021
|
John C Pepia Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
10,000
-8.28%
|
$310,000
$31.83 P/Share
|
|
Aug 30
2021
|
Mark S Ordan |
SELL
Open market or private sale
|
Direct |
95,000
-31.31%
|
$3,325,000
$35.09 P/Share
|
|
Aug 30
2021
|
Mark S Ordan |
BUY
Exercise of conversion of derivative security
|
Direct |
95,000
+23.84%
|
$1,615,000
$17.65 P/Share
|
|
Aug 10
2021
|
Roger Mack Hinson Pres., PDX & OBX Medical Group |
SELL
Open market or private sale
|
Direct |
8,799
-7.04%
|
$281,568
$32.35 P/Share
|
|
Jul 12
2021
|
Roger Md Medel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
83,092
-6.8%
|
$2,409,668
$29.77 P/Share
|
|
Jul 01
2021
|
Roger Md Medel Director |
SELL
Open market or private sale
|
Direct |
100,000
-7.56%
|
$3,000,000
$30.31 P/Share
|
|
Jun 01
2021
|
John C Pepia Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,858
-6.11%
|
$243,598
$31.98 P/Share
|
|
May 12
2021
|
Karey D Barker Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,885
+17.73%
|
-
|
|
May 12
2021
|
Waldemar, Md Carlo A Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,885
+11.75%
|
-
|
|
May 12
2021
|
Paul G Gabos Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,885
+14.33%
|
-
|
|
May 12
2021
|
Manuel Kadre Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,885
+3.64%
|
-
|